Filling the need for trusted information on national health issues…

Trial Of Experimental TB Drug First In 6 Years, Revealing Poor State Of Research On Disease

Devex: New TB drug enters first trial: The good and sad news
“The maiden human trial of a potential tuberculosis drug — the first in six years — has now commenced. Known as TBA-354, the promising drug comes from a class of chemicals known to be effective against drug-sensitive and drug-resistant tuberculosis, deemed a major public health concern because it can derail progress made in TB treatment and care. … Although considered a milestone, this news also hints at the sad state of research and development for TB drugs…” (Villarino, 2/19).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.